Drug Profile
Factor VIII biosimilar - GenBioPro
Latest Information Update: 19 Nov 2021
Price :
$50
*
At a glance
- Originator GenBioPro
- Class Antihaemorrhagics; Blood coagulation factors; Cyclic peptides; Granulocyte colony-stimulating factors; Growth hormones; Indoles; Recombinant erythropoietins; Recombinant proteins; Small molecules; Somatostatins
- Mechanism of Action Blood coagulation factor replacements; Factor X stimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Haemophilia